[2-[6-(butan-2-ylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(methanesulfonamido)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(2-methylpropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propan-2-ylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate

C100H90N20O20S10 — CID 161097566

About [2-[6-(butan-2-ylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(methanesulfonamido)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(2-methylpropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propan-2-ylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate

[2-[6-(butan-2-ylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(methanesulfonamido)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(2-methylpropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propan-2-ylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate (PubChem CID 161097566) has the molecular formula C100H90N20O20S10 and a molecular weight of 2212.61 g/mol. Its IUPAC name is [2-[6-(butan-2-ylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(methanesulfonamido)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(2-methylpropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propan-2-ylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate.

Molecular Properties

• Compound Name: [2-[6-(butan-2-ylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(methanesulfonamido)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(2-methylpropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propan-2-ylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate
• PubChem CID: 161097566
• Molecular Formula: C100H90N20O20S10
• Molecular Weight: 2212.61 g/mol
• Exact Mass: 2210.38
• IUPAC Name: [2-[6-(butan-2-ylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(methanesulfonamido)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(2-methylpropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propan-2-ylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate
• SMILES: CC(C)CS(=O)(=O)Nc1ccc2c(-c3ccccc3)nn(-c3nc(OC=O)cs3)c2c1.CC(C)S(=O)(=O)Nc1ccc2c(-c3ccccc3)nn(-c3nc(OC=O)cs3)c2c1.CCC(C)S(=O)(=O)Nc1ccc2c(-c3ccccc3)nn(-c3nc(OC=O)cs3)c2c1.CCCS(=O)(=O)Nc1ccc2c(-c3ccccc3)nn(-c3nc(OC=O)cs3)c2c1.CS(=O)(=O)Nc1ccc2c(-c3ccccc3)nn(-c3nc(OC=O)cs3)c2c1
• InChI: InChI=1S/2C21H20N4O4S2.2C20H18N4O4S2.C18H14N4O4S2/c1-14(2)12-31(27,28)24-16-8-9-17-18(10-16)25(21-22-19(11-30-21)29-13-26)23-20(17)15-6-4-3-5-7-15;1-3-14(2)31(27,28)24-16-9-10-17-18(11-16)25(21-22-19(12-30-21)29-13-26)23-20(17)15-7-5-4-6-8-15;1-13(2)30(26,27)23-15-8-9-16-17(10-15)24(20-21-18(11-29-20)28-12-25)22-19(16)14-6-4-3-5-7-14;1-2-10-30(26,27)23-15-8-9-16-17(11-15)24(20-21-18(12-29-20)28-13-25)22-19(16)14-6-4-3-5-7-14;1-28(24,25)21-13-7-8-14-15(9-13)22(18-19-16(10-27-18)26-11-23)20-17(14)12-5-3-2-4-6-12/h3-11,13-14,24H,12H2,1-2H3;4-14,24H,3H2,1-2H3;3-13,23H,1-2H3;3-9,11-13,23H,2,10H2,1H3;2-11,21H,1H3
• InChIKey: UHZKRRFGDWUPLA-UHFFFAOYSA-N
• XLogP: 19.03
• TPSA: 515.90 Ų
• H-Bond Donors: 5
• H-Bond Acceptors: 40
• Rotatable Bonds: 37
• Heavy Atoms: 150
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2212.61
LogP ≤ 5	19.03
H-Bond Donors ≤ 5	5
H-Bond Acceptors ≤ 10	40

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'aldehyde', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of [2-[6-(butan-2-ylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(methanesulfonamido)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(2-methylpropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propan-2-ylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate?

The IUPAC name of [2-[6-(butan-2-ylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(methanesulfonamido)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(2-methylpropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propan-2-ylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate (CID 161097566) is [2-[6-(butan-2-ylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(methanesulfonamido)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(2-methylpropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propan-2-ylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate.

What is the SMILES notation for [2-[6-(butan-2-ylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(methanesulfonamido)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(2-methylpropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propan-2-ylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate?

The canonical SMILES for [2-[6-(butan-2-ylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(methanesulfonamido)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(2-methylpropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propan-2-ylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate is CC(C)CS(=O)(=O)Nc1ccc2c(-c3ccccc3)nn(-c3nc(OC=O)cs3)c2c1.CC(C)S(=O)(=O)Nc1ccc2c(-c3ccccc3)nn(-c3nc(OC=O)cs3)c2c1.CCC(C)S(=O)(=O)Nc1ccc2c(-c3ccccc3)nn(-c3nc(OC=O)cs3)c2c1.CCCS(=O)(=O)Nc1ccc2c(-c3ccccc3)nn(-c3nc(OC=O)cs3)c2c1.CS(=O)(=O)Nc1ccc2c(-c3ccccc3)nn(-c3nc(OC=O)cs3)c2c1.

What is the InChIKey of [2-[6-(butan-2-ylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(methanesulfonamido)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(2-methylpropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propan-2-ylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate?

The InChIKey is UHZKRRFGDWUPLA-UHFFFAOYSA-N. The full InChI is InChI=1S/2C21H20N4O4S2.2C20H18N4O4S2.C18H14N4O4S2/c1-14(2)12-31(27,28)24-16-8-9-17-18(10-16)25(21-22-19(11-30-21)29-13-26)23-20(17)15-6-4-3-5-7-15;1-3-14(2)31(27,28)24-16-9-10-17-18(11-16)25(21-22-19(12-30-21)29-13-26)23-20(17)15-7-5-4-6-8-15;1-13(2)30(26,27)23-15-8-9-16-17(10-15)24(20-21-18(11-29-20)28-12-25)22-19(16)14-6-4-3-5-7-14;1-2-10-30(26,27)23-15-8-9-16-17(11-15)24(20-21-18(12-29-20)28-13-25)22-19(16)14-6-4-3-5-7-14;1-28(24,25)21-13-7-8-14-15(9-13)22(18-19-16(10-27-18)26-11-23)20-17(14)12-5-3-2-4-6-12/h3-11,13-14,24H,12H2,1-2H3;4-14,24H,3H2,1-2H3;3-13,23H,1-2H3;3-9,11-13,23H,2,10H2,1H3;2-11,21H,1H3.

What are the key properties of [2-[6-(butan-2-ylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(methanesulfonamido)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(2-methylpropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propan-2-ylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate?

[2-[6-(butan-2-ylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(methanesulfonamido)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(2-methylpropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propan-2-ylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate has a molecular weight of 2212.61 g/mol, XLogP of 19.03, 37 rotatable bonds, 5 hydrogen bond donors, and 40 hydrogen bond acceptors.

Where does this data come from?

All data for [2-[6-(butan-2-ylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(methanesulfonamido)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(2-methylpropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propan-2-ylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-phenyl-6-(propylsulfonylamino)indazol-1-yl]-1,3-thiazol-4-yl] formate is sourced from PubChem (CID 161097566), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).